ストックスクリーナーアプリを入手
689.45
2.34%
-16.55
アフターアワーズ：
689.00
-0.45
-0.07%
前日終値:
$706.00
開ける：
$705.63
24時間の取引高:
1.22M
Relative Volume:
1.63
時価総額：
$85.76B
収益：
$377.60B
当期純損益:
$3.35B
株価収益率:
27.49
EPS:
25.08
ネットキャッシュフロー:
$5.67B
1週間 パフォーマンス:
+2.44%
1か月 パフォーマンス:
-2.82%
6か月 パフォーマンス:
+15.35%
1年 パフォーマンス:
+22.92%
1日の値動き範囲:
$684.71
$709.50
1週間の範囲:
$667.50
$709.50
52週間の値動き範囲:
$464.42
$737.89
Mckesson Corporation Stock (MCK) Company Profile
名前
Mckesson Corporation
セクター
電話
972-446-4800
住所
6555 STATE HIGHWAY 161, IRVING, TX
MCK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
689.45 | 83.49B | 377.60B | 3.35B | 5.67B | 25.08 |
|
COR
Cencora Inc
|
292.60 | 56.29B | 316.65B | 1.91B | 1.14B | 9.72 |
|
CAH
Cardinal Health Inc
|
148.10 | 35.75B | 222.58B | 1.57B | 1.85B | 6.45 |
|
HSIC
Henry Schein Inc
|
69.60 | 8.15B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.77 | 701.93M | 2.22M | -5.63M | -1.68M | -0.24 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-04 | 再開されました | Mizuho | Neutral |
| 2024-11-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | 繰り返されました | Leerink Partners | Outperform |
| 2024-08-08 | 繰り返されました | Mizuho | Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Overweight |
| 2022-07-06 | ダウングレード | Argus | Buy → Hold |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-02-04 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-01-07 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | 繰り返されました | Barclays | Overweight |
| 2021-11-02 | 繰り返されました | BofA Securities | Buy |
| 2021-11-02 | 繰り返されました | Evercore ISI | Outperform |
| 2021-11-02 | 繰り返されました | Jefferies | Buy |
| 2021-03-30 | アップグレード | Argus | Hold → Buy |
| 2020-11-02 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-08-04 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-05-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | アップグレード | UBS | Neutral → Buy |
| 2020-04-23 | 再開されました | Credit Suisse | Neutral |
| 2020-03-18 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-13 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-08-05 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | 開始されました | Guggenheim | Neutral |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2018-10-26 | 繰り返されました | Barclays | Equal Weight |
| 2018-07-20 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2018-03-08 | 開始されました | Barclays | Equal Weight |
| 2018-02-27 | 再開されました | BofA/Merrill | Buy |
| 2018-02-02 | 繰り返されました | Mizuho | Neutral |
| 2018-01-24 | アップグレード | Jefferies | Hold → Buy |
すべてを表示
Mckesson Corporation (MCK) 最新ニュース
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
Stock Analysis | McKesson OutlookNavigating a Neutral Technical Landscape Amid Mixed Fundamentals - AInvest
McKesson Navigates Insider Sales and Institutional Confidence Amid $340M Volume, 282nd in Market - AInvest
McKesson price target raised to $772 from $766 at Wells Fargo - MSN
McKesson CEO Tyler sells $8.08 million in stock - Investing.com
McKesson Defends Payments as Rite Aid Seeks Bankruptcy Clawback - Bloomberg Law News
Now Is the Time to Reframe Your Health System Infusion Strategy – Starting with a Deliberate Design and the Right Partnerships - McKesson
How McKesson Corporation stock performs during market volatilityJuly 2025 Gainers & Consistent Income Trade Recommendations - thegnnews.com
Why McKesson Corporation stock attracts strong analyst attentionWeekly Stock Recap & Weekly High Potential Stock Alerts - beatles.ru
Chart Analysts Warn of Resistance Near McKesson Corporation Price2025 Top Gainers & Safe Capital Growth Trade Ideas - newsyoung.net
We Like The Quality Of McKesson's (NYSE:MCK) Earnings - 富途牛牛
Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability - GlobeNewswire Inc.
Can McKesson’s (MCK) Lower Earnings Shift Its Capital Allocation Priorities? - simplywall.st
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - MSN
Wells Fargo Maintains McKesson(MCK.US) With Hold Rating, Raises Target Price to $772 - 富途牛牛
Pharmacy Profiles to provide credential verification services for McKesson's Health Mart pharmacies - Drug Store News
Saudi Arabia Teleradiology Market Trends and Company Analysis Report 2025-2033 Featuring FUJIFILM, Koninklijke Philips, General Electric, Oracle, Siemens, GE, McKesson - Yahoo Finance
Wells Fargo Maintains McKesson (MCK) with Raised Price Target to $772 | MCK Stock News - GuruFocus
Wells Fargo Adjusts Price Target on McKesson to $772 From $766, Maintains Equalweight Rating - MarketScreener
The Top 5 Analyst Questions From McKesson’s Q2 Earnings Call - Yahoo Finance
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies - The Globe and Mail
J.P. Morgan Keeps Their Buy Rating on McKesson (MCK) - The Globe and Mail
McKesson Corp's shares drop below 200-day moving average, trading at $637.00 per share. - AInvest
How McKesson’s (MCK) Earnings Beat, Dividend Hike, and Spin-Off Plans Have Changed Its Investment Story - simplywall.st
Published on: 2025-08-09 00:46:56 - Newser
Published on: 2025-08-08 22:45:07 - Newser
McKesson Climbs 0.80% Despite 99th-Ranked Trading Volume as Institutional Confidence and Dividend Hike Fuel Long-Term Optimism - AInvest
Deutsche Bank Reaffirms Their Buy Rating on McKesson (MCK) - The Globe and Mail
Mizuho Securities Sticks to Their Hold Rating for McKesson (MCK) - The Globe and Mail
Here's Why McKesson (MCK) is a Strong Value Stock - Yahoo Finance
Pharmaceutical Packaging Market Trends and Company Analysis - GlobeNewswire
Pharmaceutical Packaging Market Trends and Company Analysis Report 2025-2033 Featuring Amcor, 3M, Schott, WestRock, Berry Global, McKesson, AptarGroup, Klockner Pentaplast, CCL, FlexiTuff - Yahoo Finance
Citi Sticks to Its Buy Rating for McKesson (MCK) - The Globe and Mail
McKesson’s Strong Long-Term Growth Potential Justifies Buy Rating Despite Limited Immediate Upside - TipRanks
McKesson First Quarter 2026 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Candlestick signals on McKesson Corporation stock todayBreakout Watcher with Entry and Exit Alerts - Newser
McKesson’s Earnings Call Highlights Strong Growth and Strategic Moves - TipRanks
McKesson Corp. stock underperforms Thursday when compared to competitors - MSN
Relative Strength Alert For McKesson - Nasdaq
Deutsche Bank Adjusts Price Target on McKesson to $775 From $740, Maintains Buy Rating - MarketScreener
McKesson Corporation (NYSE:MCK) Q1 2026 Earnings Call Transcript - Insider Monkey
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View - Yahoo Finance
McKesson Corp. Exceeds Expectations with Strong Q1 EarningsNews and Statistics - IndexBox
McKesson Increases Profit Forecast Due to Specialty Medicines DemandNews and Statistics - IndexBox
McKesson Achieves 23.4% Revenue Growth in Q2 CY2025News and Statistics - IndexBox
McKesson: Fiscal Q1 Earnings Snapshot - New Haven Register
Earnings call transcript: McKesson’s Q1 2026 results exceed forecasts, stock dips - Investing.com Australia
McKesson Well-Positioned to Benefit from GLP-1s and Increasing Presence in Specialty - Morningstar
McKesson Lifts Forecast As Specialty Medicine Demand Grows - Finimize
McKesson Corporation Reports Strong Q1 2026 Results - TipRanks
Decoding McKesson Corp (MCK): A Strategic SWOT Insight - GuruFocus
Mckesson Corporation (MCK) 財務データ
収益
当期純利益
現金流量
EPS
3.51%
2.04%
大文字化:
|
ボリューム (24 時間):